Flegamax syrup 120ml, carbocysteine, mucolytic effect

• Carbocysteine, mucolytic effect. The active substance in Flegamax is carbocysteine. Due to its mucolytic effect, syrup is indicated for use in diseases of the respiratory system, in the course of which a dense secretion is produced.

Flegamax syrup, carbocysteine, mucolytic effect Composition:

The active substance of the drug: carbocysteine. 1ml of syrup contains 50mg of carbocysteine ​​and auxiliary substances: sodium saccharin, methyl parahydroxybenzoate, raspberry flavor (maltodextrin (from maize), modified starch (E 1450), flavors identical to natural, flavor preparation), cochineal red (E 124 ), sodium hydroxide, carboxymethyl cellulose, purified water, sodium hydroxide, 1N aqueous solution (for pH adjustment).

Flegamax syrup, carbocysteine, mucolytic effect Action:

Carbocysteine, the active substance of the drug, affects the composition of bronchial secretions. It makes its consistency less viscous, more fluid, and thus easier to remove from the airways during coughing. The mucolytic activity of the medicinal product Flegamax supports the symptomatic treatment of respiratory diseases, which are characterized by excessive secretion with viscous, thick consistency.

Flegamax syrup, carbocysteine, mucolytic effect Use:

Flegamax is indicated for the symptomatic treatment of respiratory diseases that are associated with excessive production of viscous, thick discharge.

Flegamax syrup, carbocysteine, mucolytic effect Additional information:
Keep the product out of reach of children at room temperature. The drug contains methyl parahydroxybenzoate and cochineal red. The preparation may cause allergic reactions, also of late type. The drug contains sodium.

Flegamax syrup, carbocysteine, mucolytic effect Contraindications:
Do not use in the case of hypersensitivity to any component of the drug. Do not use in children under 6 years of age. Do not use in the asthmatic state, do not use in the case of active gastric or duodenal ulcer. It is not recommended for women during pregnancy and lactation.

Flegamax syrup, carbocysteine, mucolytic effect Side effects: Adverse reactions
may occur during use. In case of: angioedema (severe allergic reaction) with swelling of the skin and / or mucous membranes, eg in the face, extremities, joints; Stevens-Johnson syndrome (blisters that go into erosion, on the mucous membranes of the mouth, conjunctivitis, genitals), discontinue use and contact your doctor immediately. Side effects of unknown frequency: headache; abdominal pain, diarrhea, gastrointestinal bleeding, nausea and vomiting; cutaneous allergic reactions, including erythematous rash, pruritus, urticaria, drug eruption.

Flegamax syrup, carbocysteine, mucolytic effect Dosage:
It is recommended to use as per the schedule on the leaflet or as recommended by your doctor. Adults and adolescents over 12 years of age: the starting dose is 15ml three times a day, the dose should be reduced to 10ml three times a day after the onset of mucolytic activity. Children from 6 to 12 years: initial dose 5ml three times a day. It is recommended to take the prescribed dose of medicine with water. The daily dose of carbocysteine ​​in children and adolescents is 30mg / kg body weight. You can take 4-5 days without medical advice, if the symptoms have not disappeared or if the patient's condition worsened, please consult your doctor.